Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Robinhood Markets | Milan | Technology | Financial Technology (Fintech) & Infrastructure | 125.2% | €75.52B | 55.2x | 0.05 | €85.26 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Vienna | Technology | Financial Technology (Fintech) & Infrastructure | 117% | €85.96B | 67.1x | 13.16 | €331.60 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Xetra | Technology | Financial Technology (Fintech) & Infrastructure | 110.1% | €85.96B | 67.1x | 13.14 | €333.20 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | Milan | Technology | Financial Technology (Fintech) & Infrastructure | 109.6% | €85.96B | 67.1x | 13.14 | €332.85 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D Wave Quantum | Milan | 102% | €4.29B | -26.4x | 2.2 | €14.06 | 6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Neurizon Therapeutics | Frankfurt | Healthcare | Pharmaceuticals | 97.8% | €44.18M | -4.9x | 0.09 | €0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AST SpaceMobile | Milan | 91.5% | €13.84B | -26.5x | 0.4 | €40.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ProQR Therapeutics | Frankfurt | Healthcare | Biotechnology & Medical Research | 91% | €223.71M | -6.4x | 4.42 | €2.09 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ceres Power | Frankfurt | Energy | Renewable Energy | 79.2% | €211.58M | -6.5x | -0.14 | €1.06 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Milan | Healthcare | Biotechnology & Medical Research | 67% | €1.05B | 5.8x | 0.04 | €4.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Vienna | Healthcare | Biotechnology & Medical Research | 66.5% | €1.05B | 5.8x | 0.04 | €4.61 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CureVac NV | Xetra | Healthcare | Biotechnology & Medical Research | 65.4% | €1.05B | 5.8x | 0.04 | €4.65 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curevac | Frankfurt | Healthcare | Biotechnology & Medical Research | 60.4% | €1.05B | 5.8x | 0.04 | €4.65 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueprint Medicines | Frankfurt | Healthcare | Biotechnology & Medical Research | 51.5% | €7.17B | -52.7x | -1.12 | €108.80 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Milan | Technology | Software & IT Services | 43% | €23.13B | 232x | 2.15 | €126 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kinnevik B | BATS Europe | Financial | Investment Holding Companies | 37.1% | €2.35B | -10.1x | -0.15 | €8.33 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax | Frankfurt | Healthcare | Biotechnology & Medical Research | 37% | €483.02M | -2.6x | -0.22 | €7.36 | 6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philomaxcap | Frankfurt | Technology | Financial Technology (Fintech) & Infrastructure | 36.3% | €165.50M | -5.2x | 0.65 | €1.50 | -18.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosmo Pharmaceuticals NV | Vienna | Healthcare | Pharmaceuticals | 36.1% | €1.07B | 8.2x | 0.01 | €65.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | 36% | €481.75M | -2.6x | -0.22 | €7.52 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSMO Pharma | BATS Europe | Healthcare | Pharmaceuticals | 33.2% | €1.07B | 8.2x | 0.01 | €66.62 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cosmo Pharmaceuticals NV | Frankfurt | Healthcare | Pharmaceuticals | 33.1% | €1.07B | 8.2x | 0.01 | €65.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tetragon | Amsterdam | Financial | Collective Investments | 29% | €1.21B | 4.2x | €14.73 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kinnevik B | Frankfurt | Financial | Investment Holding Companies | 25.6% | €2.32B | -10.1x | -0.15 | €8.24 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Herald | BATS Europe | Financial | Collective Investments | 25.1% | €1.36B | 9.2x | 0.04 | €27.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Libertas 7 | Madrid | Real Estate | Real Estate Operations | 24.7% | €46.03M | €2.20 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Embention Sistemas Inteligentes | Paris | Industrials | Professional & Commercial Services | 24.5% | €155.55M | €24.60 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Baring | BATS Europe | Financial | Collective Investments | 22.9% | €95.88M | 6.6x | 0 | €0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invesco Mortgage Capital | Frankfurt | 21.2% | €427.04M | 15.9x | 0.11 | €6.43 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Reinet Invest | Amsterdam | Financial | Investment Banking & Investment Services | 20% | €4.80B | 6.1x | 0.11 | €26.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medincell | Paris | Healthcare | Pharmaceuticals | 20% | €535.05M | €16.20 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.6% Upside | Upgrade to Pro+ | |||
Dominari | Frankfurt | Financial | Investment Banking & Investment Services | 18.9% | €67.11M | -0.9x | 0.07 | €4.50 | 10.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BriQ Properties | Athens | Real Estate | Real Estate Operations | 18.4% | €129.14M | 3.8x | 0.05 | €2.91 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.1% Upside | Upgrade to Pro+ | |
JPMorgan EM | BATS Europe | Financial | Collective Investments | 18.2% | €1.37B | 16.9x | 0.06 | €1.36 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Temple Bar | BATS Europe | Financial | Collective Investments | 17.3% | €1.08B | 6.8x | 0.1 | €3.78 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | 17.1% | €133.74M | -3.5x | -0.03 | €1.86 | 11.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofina | Vienna | Financial | Investment Holding Companies | 16.2% | €8.96B | 6.6x | 0 | €269 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fidelity Special | BATS Europe | Financial | Collective Investments | 16.2% | €1.38B | 5.9x | 0 | €4.27 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Schroder Asia Pacific | BATS Europe | Financial | Collective Investments | 15.9% | €904.65M | 17x | 0 | €6.59 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pantheon | BATS Europe | Financial | Collective Investments | 15.5% | €1.63B | 16.5x | 0.05 | €3.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofina | Brussels | Financial | Investment Holding Companies | 15.4% | €8.96B | 6.6x | 0 | €271 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.1% Upside | Upgrade to Pro+ | |
JPMorgan Asian | BATS Europe | Financial | Collective Investments | 12.7% | €314.16M | 13.3x | 0.02 | €4.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
F&C Invest | BATS Europe | Financial | Collective Investments | 12% | €6.31B | 5.7x | 0.06 | €13.16 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mercantile | BATS Europe | Financial | Collective Investments | 12% | €2.09B | 8.1x | 0.03 | €2.90 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
All Iron Re | Madrid | Real Estate | Residential & Commercial REITs | 11% | €189.60M | 15.6x | -0.6 | €12.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phoenix Vega Mezz Plc | Athens | Financial | Investment Banking & Investment Services | 10.7% | €86.90M | 1.5x | 0 | €0.07 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blackrock Smaller | BATS Europe | Financial | Collective Investments | 10.7% | €642.08M | -145.2x | -1.5 | €15.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
City Of London IT | BATS Europe | Financial | Collective Investments | 10.6% | €2.82B | 11.1x | 0.15 | €5.71 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merchants | BATS Europe | Financial | Collective Investments | 9.5% | €961.73M | 8x | €6.49 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sofina | BATS Europe | Financial | Investment Holding Companies | 9.4% | €8.96B | 6.6x | 0 | €270.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |